CAPHA PHARMACEUTICALS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
-.--% | -.--% |
Business Summary
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
James Brown
CEO | Chief Executive Officer | - | 30/10/02 |
Janice Brown
BRD | Director/Board Member | - | 31/10/02 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
James Brown
CEO | Chief Executive Officer | - | 30/10/02 |
Janice Brown
BRD | Director/Board Member | - | 31/10/02 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 0 | 79,431,030 | 26,499,376 ( 33.36 %) | 0 | 33.36 % |
Company contact information
Capha Pharmaceuticals, Inc.
4205 Gellatly Road Suite 324
V4T 2K2, West Kelowna
+
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 64 | |
| +35.01% | 709B | |
| +30.91% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.49% | 239B | |
| +9.34% | 211B | |
| -3.19% | 203B | |
| +10.77% | 171B |
- Stock Market
- Equities
- FPSUF Stock
- Company Capha Pharmaceuticals Inc.
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return**#ffffff**/services/solutions/**#004eff**#000000**Replicate our performance**1**
#252525**/registration/member/**Blanc**7**To continue browsing, please register!**#ffffff50**14px**#33d251**
